By Clay Davis Published September 29, 2016
In the months preceding the 2016 Rio de Janeiro Olympic Games, a new mosquito borne public health crisis called Zika shook Latin America. Usually, the Zika virus is relatively benign. The virus has hit some areas of the United States and territories especially hard. And on February 22nd, the Obama administration requested $1.9 billion in emergency funding for Zika from Congress.
By Clay Davis Published November 2, 2015
Rising pharmaceutical costs in the United States are the result of unrestricted spending in a growing market. Pharmaceutical companies are mostly concerned with selling products at high costs. This would not happen in a single payer system, because price is carefully negotiated for each patient group. However, in the United States negotiation is impossible even in the large government run Medicare program. Here, a policy called external reference pricing should be considered. In this system, drug prices are based on the median of prices in other countries of comparable size.